Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Tables 1 and 2 summarize the major clinical applications supported by evidence from randomized controlled trials and ongoing phase III trials
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 276,54 per year only 23,05 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
A Phase 2 randomised controlled trial published in the New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023) reported that participants receiving higher doses of retatrutide (up to 12 mg) achieved mean body weight reductions of approximately 1724% over 48 weeks
Androgenetic alopecia unmasking Rapid weight loss and hormonal shifts can unmask or accelerate androgenetic alopecia (pattern hair loss) in genetically susceptible individuals
Doctors often suggest Anucobal-1500 for patients with neuropathic pain or fatigue
US$ 23.20
.jpeg)
US$ 28.30
US$ 20.59
US$ 29.50
US$ 28.50
US$ 23.67
US$ 25.59
US$ 26.06
US$ 19.98
